The Amapola Test: description of a novel screening tool for visual alterations in primary care
Family Practice · 11.06.2026 · 43 (4)
DOI: 10.1093/fampra/cmag034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Family Practice, online erschienen am 06.07.2026. Verfasst von Albert Arnaiz-Camacho und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Hospital Universitari Vall d'Hebron, Pg. de la Vall d'Hebron 119, Barcelona 08035, Spain. Hauptthemen laut MEDLINE: Vision Disorders, Vision Screening, Vision Tests. Die Arbeit nennt 17 Literaturangaben. Gefördert von: Fundació Catalana d'Oftalmologia (Societat Catalana d'Oftalmologia-SCOFT).
Abstract (Originalsprache)
Purpose
To describe a novel screening tool for the detection of visual alterations in primary care.
Methods
A prospective study was conducted in order to assess concordance and feasibility of the Amapola Test. In patients with a visual complaint, a primary care resident physician identified the visual symptom using the Amapola Test and the results were then compared with an expert history-taking conducted by an ophthalmologist.
Results
The Amapola Test was administered to 350 patients with visual disturbances. Of these, 321 patients identified the symptom on the visual charts. The test showed a high concordance rate, with a usability of 89.4% (95% CI: 86.2%–92.6%). The most frequently identified visual symptoms were blurred vision (109), isolated floaters (75), floaters combined with photopsia (23), and isolated photopsia (20). The most common diagnoses were posterior vitreous detachment (100), migraine visual aura (28), and exudative age-related macular degeneration (19).
Conclusion
The Amapola Test allows for correct identification of visual symptoms. This study demonstrates a high level of concordance between patient-reported symptoms using the test and expert clinical history, and indicates potential application as a supportive tool in primary care. However, further studies in real-life settings are needed to demonstrate its usefulness and to evaluate its diagnostic performance. Clinical trial number not applicable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Hospital Universitari Vall d'Hebron, Pg. de la Vall d'Hebron 119, Barcelona 08035, Spain.
ORCID-Profile: Albert Arnaiz-Camacho
Förderung
- Fundació Catalana d'Oftalmologia (Societat Catalana d'Oftalmologia-SCOFT)
Zitieren
APA
Arnaiz-Camacho, A., Castany-Aregall, M., Pairó-Salvador, A., García-Hidalgo, S., Pablos-Jiménez, T., Bertolani, Y., Alarcón-Portabella, S., & Zapata, M. Á. (2026). The Amapola Test: description of a novel screening tool for visual alterations in primary care. Family Practice, 43(4). https://doi.org/10.1093/fampra/cmag034
Vancouver
Arnaiz-Camacho A, Castany-Aregall M, Pairó-Salvador A, García-Hidalgo S, Pablos-Jiménez T, Bertolani Y, et al. The Amapola Test: description of a novel screening tool for visual alterations in primary care. Family Practice. 2026;43(4). doi:10.1093/fampra/cmag034
BibTeX
@article{ArnaizCamacho2026,
author = {Arnaiz-Camacho, Albert and Castany-Aregall, Marta and Pairó-Salvador, Armand and García-Hidalgo, Sara and Pablos-Jiménez, Tatiana and Bertolani, Yann and Alarcón-Portabella, Sílvia and Zapata, Miguel-Ángel},
title = {The Amapola Test: description of a novel screening tool for visual alterations in primary care},
journal = {Family Practice},
year = {2026},
volume = {43},
number = {4},
doi = {10.1093/fampra/cmag034}
}
EUVIMED